Here are five key notes:
1. Medtronic inherited most of its medical supplies business in 2014 when the company acquired Covidien for $42.9 billion. The sale would likely streamline integration of the two companies.
2. Cardinal Health is reportedly in “exclusive talks” with Medtronic about acquiring the business, and CNBC reported a deal could be reached this month.
3. If the two companies are able to reach a deal, the purchase would boost Cardinal Health’s efforts to build its medical products business; the company acquired Cordis from Johnson & Johnson in 2015 in an attempt to add to its portfolio.
4. The medical products business of Cardinal Health is on track to reach mid- to high-single digit revenue growth, according to the report.
5. Neither Medtronic nor Cardinal Health commented in the report, and the deal could still fall through.
